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Background: Ginseng has been shown to exert antistress effects both in vitro and in vivo. However, the
effects of ginseng on stress in brain cells are not well understood. This study investigated how Korean
Red Ginseng (KRG) controls hydrogen peroxide-induced apoptosis via regulation of phosphatidylinositol-
3 kinase (PI3K)/Akt and estrogen receptor (ER)-b signaling.
Methods: Human neuroblastoma SK-N-SH cells were pretreated with KRG and subsequently exposed to
H2O2. The ability of KRG to inhibit oxidative stress-induced apoptosis was assessed in MTT cytotoxicity
assays. Apoptotic protein expression was examined by Western blot analysis. The roles of ER-b, PI3K, and
p-Akt signaling in KRG regulation of apoptosis were studied using small interfering RNAs and/or target
antagonists.
Results: Pretreating SK-N-SH cells with KRG decreased expression of the proapoptotic proteins p-p53
and caspase-3, but increased expression of the antiapoptotic protein BCL2. KRG pretreatment was also
associated with increased ER-b, PI3K, and p-Akt expression. Conversely, ER-b inhibition with small
interfering RNA or inhibitor treatment increased p-p53 and caspase-3 levels, but decreased BCL2, PI3K,
and p-Akt expression. Moreover, inhibition of PI3K/Akt signaling diminished p-p53 and caspase-3 levels,
but increased BCL2 expression.
Conclusion: Collectively, the data indicate that KRG represses oxidative stress-induced apoptosis by
enhancing PI3K/Akt signaling via upregulation of ER-b expression.
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
The a and b estrogen receptors (ERs) regulate various brain
functions in an estradiol-dependent manner. Signaling pathways
elicited via ER-a and ER-b activation are interrelated and feedback
inhibition occurs mainly by estradiol engagement of the ER-a re-
ceptor. Most studies involving ER-b have focused on brain functions
and behavioral patterns [1,2]. ER-b is a member of the nuclear re-
ceptor superfamily [3]. Upon ligand binding, ER-b regulates gene
expression by binding directly to regulatory regions of target genes
or by interacting with other transcription factors such as nuclear
factor kB, activating protein 1, and stimulating protein 1 [4]. ER-b
also controls gene expression by activating signaling pathways thatyunkwan University, 300 Chunchu
erms of the Creative Commons At
ribution, and reproduction in any
e Korean Society of Ginseng, Publstimulate kinases such as protein kinase A, protein kinase C, and
mitogen-activated protein kinase [5]. Recent studies show that ER-
b has neuroprotective, anti-inﬂammatory, antiproliferative, anti-
oxidant, and immune-modulatory activities [2,6]. However, the
effects of stress on ER-b expression in the brain cells remain largely
unknown.
ERs regulate activation of phosphatidylinositol-3 kinases
(PI3Ks) by interacting with the p85 regulatory subunit of PI3K
[7]. Activation of ER-a upregulates PI3K/Akt signaling, which in
turn stimulates cell growth in breast cancer cells [8]. ER-b also
activates signaling through PI3K/Akt and improves myocardial
function in female hearts following acute ischemia [9]. PI3Ks
are a family of kinases that phosphorylate the 30-OH group ofn-dong, Su-Won 440-746, Korea.
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ond messenger phosphatidylinositol-3,4,5-trisphosphate [10],
which can bind to and activate Akt (p-Akt). Akt activation plays
a key role in cell proliferation, cell cycle progression, and
apoptosis [10]; thus, PI3K/Akt signaling is important for cell
survival.
Panax ginseng Meyer is one of the most popular herbal medi-
cines in Korea, and has long been used in Asian countries for
stimulating immunity and inhibiting various cancers [11e13].
Ginsenosides are active compounds present in ginseng that are
known to have antioxidative, anti-inﬂammatory, and anticancer
activities [14]. Ginsenoside Rb1, a known phytoestrogen, shows
anti-inﬂammatory activity in smooth muscle cells [15] and inhibits
interleukin-1b-induced apoptosis in human chondrocytes [16].
Ginsenoside Rg3 exerts neuroprotective, anti-inﬂammatory, and
antioxidative effects [17,18]. Although the role of ginseng in regu-
lating the development of cancer is well deﬁned, the mechanism by
which it protects brain cells from oxidative stress is not well un-
derstood. Recent studies have revealed that ginseng upregulates
ER-b expression in vitro and in vivo [17,19]. Previously, we reported
that Korean Red Ginseng (KRG)-induced ER-b expression inhibits
oxidative stress-induced apoptosis in mouse brain and SK-N-SH
neuroblastoma cells by inhibiting PADI4 expression [17]. However,
the downstream signaling effector molecules of ER-b have not been
explored. Thus, the aims of this study were to identify signaling
effector molecules immediately downstream of ERb and to under-
stand how KRG-induced ER-b expression regulates apoptosis via
PI3K/Akt signaling in oxidative stressed brain cells.
2. Materials and methods
2.1. Cell culture and KRG
Human neuroblastoma SK-N-SH cells (catalog number HTB-11;
ATCC, Manassas, VI, USA) were cultured in RPMI 1640 (Lonza,
Walkersville, MD, USA) media containing 10% FBS, 1% penicillin-
streptomycin (10,000 U penicillin/mL, 10,000 mg streptomycin/mL),
1mM HEPES, 1mM sodium pyruvate, 4.5 g/L glucose, 1.5 g/L bicar-
bonate, and 2mM L-glutamine at 37C, and 5% CO2.
KRG extract was manufactured by Korea Ginseng Corporation
(Seoul, Korea) by steaming and drying 6-year-old roots from Panax
ginseng Meyer and analyzed as described previously [17]. The gin-
senoside content of KRG extracts used in this study was: Rg1
0.71 mg/g, Re 0.93 mg/g, Rf 1.21 mg/g, Rh1 0.78 mg/g, Rg2(s)
1.92 mg/g, Rg2(r) 1.29 mg/g, Rb1 4.62 mg/g, Rc 2.41 mg/g, Rb2
1.83 mg/g, Rd 0.89 mg/g, Rg3(s) 2.14 mg/g, and Rg3(r) 0.91 mg/g.
2.2. Inhibitor treatments
Speciﬁc inhibitors of ER-b (PHTPP: catalog number sc-204191)
and Akt (inhibitor VIII; catalog number sc-2002048) were pur-
chased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
The PI3K-speciﬁc inhibitor LY294002 (catalog number L9908) was
purchased from SigmaeAldrich (St Louis, MO, USA). SK-N-SH cells
were treatedwith KRG extract for 48 h and subsequently treated with
5mMPHTPP [20], 80mM LY294002 [21], or 50mMAkt inhibitor VIII for
5 h.
2.3. RNA interference studies
ER-b expression in SK-N-SH cells was silenced by transfecting
cells with 50nM ER-b small interfering RNA (siER-b; Santa Cruz
Biotechnology, Inc), using the TransIT-TKO transfection reagent
(Mirus, Madison, USA) as described [17].2.4. MTT assays
The effects of KRG treatment on cell viability were determined
by MTT assays to assess mitochondrial function [22]. SK-N-SH cells
were seeded in 96well-plate and incubatedwith KRG (1mg/mL) for
48 h and subsequently treatedwith 0.5mMH2O2 for 2 h. Next, RPMI
medium containing MTT dye (2 mg/mL) was added to cell cultures,
and plates were incubated for 1 h at 37C with 5% CO2. Superna-
tants were then removed,150 ml of dimethyl sulfoxide was added to
wells for 15 min to solubilize liberated formazan, and absorbance
was read at 540 nm with a plate reader. Experiments were per-
formed in triplicate.
2.5. Western blot analysis
Cells were washed with phosphate-buffered saline (PBS), har-
vested, and collected by centrifugation. Cell pellets were lysed in
radioimmunoprecipitation assay buffer containing 50mM Tris-Cl
pH 7.4, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate,
150mM NaCl, 1mM ethylenediaminetetra-acetic acid, 1mM phe-
nylmethylsulfonyl ﬂuoride, and 1 protease inhibitor cocktail.
Protein concentrations in samples were determined by Bradford
assays, and 30e40 mg of protein from each samplewere resolved on
12.5% sodium dodecyl sulfate polyacrylamide gel electrophoresis
gels. Samples were transferred to polyvinylidene diﬂuoride mem-
branes (Millipore, Billerica, MA, USA), which were blocked on a
shaker at room temperature for 2e3 h in Tris-buffered saline with
0.1% Tween-20 (T-TBS) containing 7% skim milk. Membranes were
then washed three times with T-TBS and incubated overnight with
primary antibodies at 4C. Primary antibodies recognizing human
ER-b (sc-53494), bcl-2 (sc-7382), p-p53 (sc-101762), PI3K-p110 (sc-
7189), Akt (sc-8312), and p-Akt (sc-7985-R) were purchased from
Santa Cruz Biotechnology, Inc. Primary antibodies recognizing b-
actin and anti-caspase-3 were obtained from SigmaeAldrich and
Cell Signaling Technology (Beverley, MA, USA), respectively. Sub-
sequently, membranes were washed 4 times with T-TBS and incu-
bated for 1 h at room temperature with horseradish peroxidase-
conjugated anti-rabbit or anti-mouse secondary antibodies
(SigmaeAldrich). Membranes werewashed in T-TBS and proteins of
interest were detected using the Power Optic-ECLWestern blotting
Detection reagent (Animal Genetics Inc., Gyeonggi-do, Korea).
2.6. Statistical analysis
Statistical differences between group medians from three in-
dependent experiments were analyzed by analysis of variance.
Differences were considered statistically signiﬁcant in cases where
p < 0.05.
3. Results
3.1. Inhibition of ER-b-mediated inhibition of apoptotic signaling
during oxidative stress
Previously, we showed that ER-b expression is inhibited by
oxidative stress and upregulated following exposure to KRG [17].
ER-b is an upstream regulator of apoptosis [23,24]. Here, we
examined whether KRG inhibits oxidative stress-induced apoptosis
via ER-b upregulation (Fig. 1). ER-b expression was blocked by
transfecting SK-N-SH cells with siER-b prior to treating cells with
0.5mM H2O2 to cause oxidative stress. Cytotoxicity was examined
by MTT assays, and expression of apoptotic markers such as p-p53,
capase-3, and BCL2 were determined. Results showed that oxida-
tive stress reduces SK-N-SH cell viability, that KRG pretreatment
protects against oxidative stress-induced cytotoxicity, and that the
A B
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Fig. 1. Estrogen receptor-b small interfering RNA inhibits apoptosis in SK-N-SH cells resulting from oxidative stress. SK-N-SH cells were transfected for 24 h with 40nM estrogen
receptor-b small interfering RNA. Following transfection, cells were incubated with Korean Red Ginseng extract (1 mg/mL) for 48 h and then with 0.5mM H2O2 for 2 h. (A) Cell
viabilities were determined by MTT assays. (B) Cell lysates were used to estimate protein expression levels by Western blot analysis. (C) Quantiﬁcation of at least three independent
experimental results from (B). Statistical signiﬁcances were determined by analysis of variance. Data shown are representative of three independent experiments. *p < 0.05.
**p < 0.01. ***p < 0.001.
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(Fig. 1A). Expression of the antiapoptotic protein BCL2 was also
suppressed by siER-b transfection (Fig. 1B, 1C). By contrast,
expression of proapoptotic factors such as p-p53 and caspase-3
were enhanced by siER-b transfection. However, KRG-treatment
upregulated BCL2 expression and downregulated expression of p-
p53 and caspase-3 (Fig. 1B,1C), indicating that KRG protects against
apoptosis induced by oxidative stress.
To conﬁrm these observations, we studied the effects of an ER-b
antagonist (PHTTP) on cell viability and expression of apoptotic
markers in oxidative stressed brain cells. The ER-b inhibitor
consistently reduced cell viability during oxidative stress,
compared with dimethyl sulfoxide-treated control cells (Fig. 2A).
Moreover, ER-b inhibitor treatment decreased BCL2 expression but
increased p-p53 and caspase-3 levels (Fig. 2B, 2C). These results
suggest that KRG prevents oxidative stress-induced apoptosis by
inhibiting ER-b-dependent apoptotic signaling.
3.2. ER-b inhibition suppresses Akt/PI3K signaling in oxidatively
stressed brain cells
Akt plays important roles in cell survival and apoptosis [25,26]
and blocks apoptosis by inhibiting caspase-3 expression and
enhancing BCL2 expression [26,27]. Thus, it was hypothesized that
ER-b regulates Akt activation to promote inhibition of apoptosis in
oxidatively stressed brain cells. To test this hypothesis, ER-bexpression was silenced by transfecting cells with siER-b and the
effect of ER-b downmodulation on Akt expression was determined.
As expected, siER-b transfection reduced p-Akt levels but not total
Akt levels. By contrast, KRG pretreatment increased p-Akt expres-
sion, thus enhancing cell survival under conditions of oxidative
stress (Fig. 3A, 3B). Moreover, treatment with the ER-b inhibitor
PHTTP decreased p-Akt levels marginally, whereas KRG treatment
increased basal p-Akt levels signiﬁcantly without increasing Akt
levels (Fig. 3C, 3D).
Because PI3K is an upstream regulator of Akt, ER-bedependent
Akt activation (p-Akt) may be in part mediated by PI3K upregu-
lation. To test this possibility, the effect of siER-b silencing on PI3K
levels during oxidative stress was determined by Western blot
analysis. The results show that oxidative stress, but not siER-b
transfection, decreases PI3K levels compared to negative controls
(Fig. 3A, 3B). However, KRG treatment signiﬁcantly upregulated
PI3K expression compared to the PBS group. Neither oxidative
stress nor siER-b transfection decreased PI3K levels back to the
normal nonstressed control level (Fig. 3A, 3B). Consistently,
treatment with the ER-b inhibitor PHTTP resulted in a moderate
although nonsigniﬁcant decrease in PI3K expression levels.
However, KRG treatment upregulated PI3K levels compared to the
PBS group (Fig. 3C, 3D). These results suggest that KRG upregu-
lates ER-b-mediated PI3K/Akt signaling in brain cells even under
conditions of oxidative stress, which normally diminishes PI3K/
Akt signaling.
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Fig. 2. The estrogen receptor-b inhibitor PHTPP inhibits apoptosis in SK-N-SH cells resulting from oxidative stress. SK-N-SH cells were incubated sequentially with Korean Red
Ginseng extract (1 mg/mL) for 48 h, 5mM PHTPP for 5 h, and 0.5mM H2O2 for 2 h. (A) Cell viabilities were determined by MTT assays. (B) Cell lysates were used to estimate protein
expression levels by Western blot analysis. (C) Quantiﬁcation of at least three independent experimental results from (B). Statistical signiﬁcances were determined by analysis of
variance. Data shown are representative of three independent experiments. *p < 0.05. **p < 0.01. ***p < 0.001.
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Fig. 3. Functional estrogen receptor (ER)-b inhibition suppresses phosphatidylinositol-3 kinase/Akt signaling in SK-N-SH cells resulting from oxidative stress. (A) SK-N-SH cells were
transfected with 40nM ER-b small interfering RNA for 24 h and then incubated with 1 mg/mL of Korean Red Ginseng extract for 48 h. (B) SK-N-SH cells were incubated with 1 mg/
mL of Korean Red Ginseng extract for 48 h and then exposed to the ER-b inhibitor PHTPP (5 mM) for 5 h. Following the indicated treatments, cells from (A) and (B) were incubated
with H2O2 for 30 min, and Western blots were performed to estimate gene expression levels in cell lysates. (C, D) Quantiﬁcation of at least three independent experimental results
from (A, B). Statistical signiﬁcances were determined by analysis of variance. Data shown are representative of three independent experiments. *p < 0.05. ***p < 0.001.
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during oxidative stress
To examine further whether the PI3K/Akt signaling pathway is
important in the apoptosis of oxidative stressed brain cells, SK-N-
SH cells were treated with the PI3K inhibitor LY294002, and the
expression levels of apoptotic markers were determined. Oxidative
stress repressed p-Akt levels compared with nonstressed control
cells, but induced p-p53 expression (Fig. 4A). In addition, treatment
with the PI3K inhibitor LY294002 signiﬁcantly lowered p-Akt levels
in both PBS- and KRG-treated groups compared to control cells, but
KRG treatment signiﬁcantly increased p-Akt expression compared
to the PBS-treated group. However, total Akt levels were unaffected
by PI3K inhibition (Fig. 4A, B). These results suggest that oxidative
stress inhibits p-Akt expression but that KRG reverses such inhi-
bition and increases cells survival. Furthermore, PI3K inhibition
inhibited BCL2 expression, but induced p-p53 and caspase-3
expression. However, KRG treatment reversed this result, and
increased BCL2 level but decreased p-p53 and caspase-3 levels
were observed (Fig. 4A, 4B), indicating that KRG protects the brainA
C
Fig. 4. Inhibition of phosphatidylinositol-3 kinase/Akt signaling counteracts apoptosis in oxi
Red Ginseng extract for 48 h. Subsequently, cells were exposed for 6 h to 80mM of phosphati
then treated with H2O2 for 30 min. Cell lysates were subject to Western blot analysis to estim
independent experimental results from (A, B). Statistical signiﬁcances were determined by a
*p < 0.05. **p < 0.01. ***p < 0.001.cells from apoptosis from oxidative stress via upregulation of PI3K
signals.
To conﬁrm these results, Akt inhibitor VIII was used to inhibit
Akt activity, and apoptosis marker expressions were checked in
oxidative stressed brain cells. Results show that Akt inhibition
downregulates BCL2 expression, but upregulates caspase-3
expression compared to solvent controls (Fig. 4C, 4D). However,
KRG treatment resulted in increased BCL2 expression and
decreased caspase-3 and p-p53 levels (Fig. 4C, 4D). These results
suggest that KRG inhibits apoptosis via upregulation of PI3K/Akt
signals in oxidative stressed brain cells.
4. Discussion
Brain myelin sheaths contain relatively large amounts of iron
and lipids and have high rates of oxidative metabolismwith limited
antioxidant capacity. Thus, myelin sheaths are highly susceptible to
oxidative damage [28e30]. Moreover, oxidative stress due to free
radicals has been implicated as a major pathological mechanism of
brain disorders, such as Parkinson’s disease, Alzheimer’s disease,B
D
dative stressed brain cells. (A, B) SK-N-SH cells were incubated with 1 mg/mL of Korean
dylinositol-3 kinase inhibitor LY294002 (A) or 50mM of Akt inhibitor VIII (B). Cells were
ate protein levels of interest following treatment. (C, D) Quantiﬁcation of at least three
nalysis of variance. Data shown are representative of three independent experiments.
Fig. 5. Upregulation of estrogen receptor (ER)-b by Korean Red Ginseng extract in-
hibits apoptosis in oxidative stressed brain cells. Oxidative stress suppresses ER-b,
which is required for the activation of phosphatidylinositol-3 kinase (PI3K)/Akt signals.
Activation of PI3K/Akt signals induces antiapoptotic factors or represses proapoptotic
factors. Korean Red Ginseng extract induces ER-b, leading to the upregulation of PI3K/
Akt signals, thereby inhibiting apoptosis in the brain.
J Ginseng Res 2015;39:69e7574and brain trauma [31,32]. In the brain, stress stimulates secretion of
glucocorticoids, which augments the extracellular accumulation of
glutamate in the hippocampus. Because glutamate can induce
neuronal excitotoxicity and leads toTNF-a release, such an outcome
would activate iNOS and COX2 induction and generate free radicals,
which can mutate DNA, oxidize proteins and lipids, and ﬁnally re-
sults in neural degeneration and cell death [33]. Therefore, devel-
opment of a potential candidate for various degenerative disorders
in the brain is required.
The PI3K/Akt pathway plays an important role in neural survival
pathways [34]. PI3K is an upstream antiapoptotic effector in the
growth factor signaling pathway. Akt is also a key antiapoptotic
effector of cellular growth factors [35]. PI3K activation by growth
factors leads to Akt activation, which is an important player in sur-
vival pathway [36]. Some studies have shown that Akt suppresses
apoptosis signaling via BCL2 induction [27], and p-p53 inhibition
through MDM2 activation [37]. Previously, KRG was shown to
upregulate PI3K/Akt signaling and to inhibit apoptosis via the regu-
lation of BCL2 and caspase-3 expression, thus protecting endothelial
cells from starvation [38]. Moreover, Panax notoginseng saponins
inhibit ischemia-induced apoptosis by stimulating PI3K/Akt
signaling in cardiomyocytes [39]. However, themechanismbywhich
KRG activates PI3K/Akt signal via ER-b under oxidative stress in brain
cells has been unclear until now. In this study, we demonstrated that
KRG increases PI3K/Akt signaling via upregulation of ER-b, thus
inhibiting apoptosis through p-p53 and caspase-3 downregulation
and BCL2 induction in oxidatively stressed brain cells.
Excitotoxicity is the pathological process caused by neuro-
transmitter glutamate such as N-methyl-D-aspartate (NMDA) and
kainic acid [40]. These excitotoxins bind to glutamate receptor and
result in increase of intracellular Ca2þ. Subsequently, overload of
intracellular Ca2þ stimulates activation of enzymes comprising
calpains, which are the ubiquitously expressed family of Ca2þ-
dependent proteases [40]; thus these enzymes can damage cellular
structures such as cytoskeleton, and are important for apoptosis
and necrosis. Estrogen induced ER-a inhibited excitotoxicity via
downregulating calpain expression [41]. In addition, ER-b play an
important role in estrogenic neuroprotection against NMDA-
induced excitotoxicity [42]. Red ginseng extract was reported to
have neuroprotective activity against kainic acid-induced excito-
toxicity in vitro and in vivo by inhibition of ROS level [40]. Moreover,
ginsenoside Rg3 exhibited neuroprotection against homocysteine-
induced excitotoxicity via inhibition of homocysteine-mediated
NMDA receptor activation [43]. Our results showed that KRG in-
creases ER-b expression and provides ER-b mediated-neuro-
protection. Taken together, KRG-induced ER-b seems to play some
role in protection against excitotoxicity. However, further studies
are necessary for elucidation of the underlying mechanism.
Ginsenosides are structurally similar to glucocorticoids or es-
trogens. In agreement, ginsenosides Re and Rg1 are functional li-
gands of the glucocorticoid receptor, whereas ginsenosides Rb1 and
Rh1 are functional ligands of the ER [44]. Ginseng was also shown
to activate ER in breast cancer cells in vitro but not in vivo [19].
Previously, we found that the ER-a expression was not affected in
vitro by oxidative stress nor by KRG treatment, thus ERawould not
be predicted to play amajor role in oxidative stress in the brain [17].
In this study, KRG extract was shown to inhibit oxidative stress-
induced apoptosis in neuroblastoma cells. This apoptosis inhibition
is mediated by ER-b upregulation via the PI3K/Akt signaling
pathway. The upregulation of PI3K/Akt signaling inhibits apoptotic
signals by decreasing p-p53 and caspase-3 expression, but
increasing BCL2 expression. Therefore, KRG protects brain cells
from oxidative stress-induced cell death. Collectively, these data
suggest that activation of ER-b by KRG inhibits apoptosis in
oxidative stressed brain cells (Fig. 5).Conﬂicts of interest
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